A Rising Public Health Concern: Understanding the STI Surge in Europe
Public health authorities are raising alarms as data from the European Centre for Disease Prevention and Control (ECDC) reveals that sexually transmitted infections (STIs) have reached record levels across Europe. With sustained transmission occurring over the last decade, experts are calling for urgent updates to national prevention strategies to address these widening gaps in care.
The Scale of the STI Epidemic
The numbers reflect a significant shift in the landscape of infectious diseases. According to the latest data, gonorrhea cases reached 106,331 in 2024, marking a 303% increase since 2015. Syphilis has similarly seen a surge, more than doubling over the same period to 45,577 cases. Chlamydia remains the most frequently reported STI, with 213,443 cases, while lymphogranuloma venereum (LGV) continues to circulate with 3,490 reported cases.
“Sexually transmitted infections have been on the rise for 10 years and reached record high levels in 2024. Untreated, these infections can cause severe complications, such as chronic pain and infertility and, in the case of syphilis, problems with the heart or nervous system,” says Bruno Ciancio, Head of Unit, Directly Transmitted and Vaccine-Preventable Diseases at the ECDC.
Congenital Syphilis: A Growing Crisis
Perhaps most concerning is the near doubling of congenital syphilis cases, which rose from 78 in 2023 to 140 in 2024 across 14 reporting countries. This condition occurs when an infection is passed directly to a newborn, potentially leading to lifelong complications. The ECDC attributes this rise to missed prevention opportunities, including deficiencies in antenatal screening, lack of follow-up, and inadequate repeat testing during pregnancy.
Pro-Tip: Protecting Your Sexual Health
- Use Barrier Protection: Consistent use of condoms with new or multiple partners remains the most straightforward way to prevent transmission.
- Get Tested: Do not wait for symptoms to worsen. Seek testing if you experience pain, discharge, or notice any ulcers.
- Consult Providers: If you are at a higher risk of exposure, speak with your healthcare provider about tailored prevention options.
Barriers to Effective Prevention
Current national strategies are struggling to keep pace with post-pandemic behavioral changes. The ECDC report highlights that 13 of 29 reporting countries still impose out-of-pocket costs for basic STI tests, creating a financial barrier to care. The uneven implementation of services means that access to screening and treatment is not uniform across the continent.
The Role of Doxy-PEP
To support prevention, the ECDC recently provided guidance on the use of doxycycline for post-exposure prophylaxis (doxy-PEP) for individuals at higher risk of exposure. However, the organization cautions against the widespread use of doxy-PEP for gonorrhea due to the high risk of antimicrobial resistance, which could render current treatments less effective in the future.
Frequently Asked Questions (FAQ)
- Why are STI rates increasing? Factors include gaps in antenatal screening, outdated national prevention strategies, and barriers such as out-of-pocket costs for testing.
- What is congenital syphilis? It is a condition where a mother transmits syphilis to her baby during pregnancy, which can result in severe, lifelong health complications for the newborn.
- Is doxy-PEP recommended for everyone? No. The ECDC suggests it only for those facing higher exposure risks and advises against its broad use for gonorrhea due to concerns over antimicrobial resistance.
Did You Know?
The ECDC is actively monitoring over 50 infectious disease topics to provide guidance to countries on how to prevent and respond to outbreaks, ensuring that public health data is used to inform effective policy.
How are your local public health services handling STI screenings? Share your thoughts in the comments below, or subscribe to our newsletter for the latest updates on global health trends.